These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38906800)

  • 1. Management of Graves' ophthalmopathy by radiotherapy: A literature review.
    Beige A; Boustani J; Bouillet B; Truc G
    Cancer Radiother; 2024 Jun; 28(3):282-289. PubMed ID: 38906800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Graves' ophthalmopathy.
    González-García A; Sales-Sanz M
    Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
    Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D
    Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical Guidelines Management of Graves Ophthalmopathy.
    Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
    Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of orbital radiotherapy in moderate-to-severe active graves' orbitopathy including long-lasting disease: a retrospective analysis.
    Choi JH; Lee JK
    Radiat Oncol; 2020 Sep; 15(1):220. PubMed ID: 32958019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel observational study protocol to develop a prediction model that identifies patients with Graves' ophthalmopathy insensitive to intravenous glucocorticoids pulse therapy.
    Wang Y; Wang H; Li L; Li Y; Sun J; Song X; Zhou H
    BMJ Open; 2021 Dec; 11(12):e053173. PubMed ID: 34916318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy.
    Li YJ; Luo Y; He WM; Li P; Wang F
    Radiat Oncol; 2017 Nov; 12(1):171. PubMed ID: 29110673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
    Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
    Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
    Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
    J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids.
    Ma Z; Ozaki H; Ishikawa Y; Jingu K
    Jpn J Radiol; 2019 Aug; 37(8):612-618. PubMed ID: 31201593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbital radiotherapy in the management of Graves' orbitopathy--current state of knowledge.
    Ruchała M; Hernik A; Zybek A
    Endokrynol Pol; 2014; 65(5):388-96. PubMed ID: 25301490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials.
    Viani GA; Boin AC; De Fendi LI; Fonseca EC; Stefano EJ; Paula JS
    Arq Bras Oftalmol; 2012 Oct; 75(5):324-32. PubMed ID: 23471326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review.
    Bello OM; Druce M; Ansari E
    BMJ Open Ophthalmol; 2024 Jun; 9(1):. PubMed ID: 38886120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.
    Guler OC; Onal C; Arslan G
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):299-303. PubMed ID: 26466836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
    Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM;
    Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Genere N; Stan MN
    Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.